TickerFacts.

Castle Biosciences Inc (CSTL): Shareholders' Equity

Annual figures by period end, from SEC filings.

$470.87M
As of 2025-12-31
$470.03M
As of 2026-06-30
+5.7%
3-year compound annual growth
+2.5%
5-year compound annual growth
2018-12-31: -$56.57M2019-12-31: $85.11M2020-12-31: $415.69M2021-12-31: $411.74M2022-12-31: $399.15M2023-12-31: $391.27M2024-12-31: $455.83M2025-12-31: $470.87M$470.87M
2018-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$470.87M+3.3%2026-02-26, Balance as of period end
2024-12-31$455.83M+16.5%2026-02-26, Balance as of period end
2023-12-31$391.27M-2.0%2026-02-26, Balance as of period end
2022-12-31$399.15M-3.1%2025-02-27, Balance as of period end
2021-12-31$411.74M-1.0%2023-02-28, Balance as of period end
2020-12-31$415.69M+388.4%2022-02-28, Balance as of period end
2019-12-31$85.11Mn/m2021-03-11, Balance as of period end
2018-12-31-$56.57Mn/a2020-03-10, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Castle Biosciences Inc (CSTL)2025-12-31$470.87M+3.3%
Fulgent Genetics, Inc. (FLGT)2025-12-31$1.11B-1.9%
CareDx, Inc. (CDNA)2025-12-31$303.10M-19.9%
BillionToOne, Inc. (BLLN)2025-12-31$480.11Mn/m
Veracyte, Inc. (VCYT)2025-12-31$1.31B+11.4%
GRAIL, Inc. (GRAL)2025-12-31$2.58B+3.0%
Caris Life Sciences, Inc. (CAI)2025-12-31$577.31Mn/m
Guardant Health, Inc. (GH)2025-12-31-$99.31Mn/m
Biodesix Inc (BDSX)2025-12-31-$2.46Mn/m

Compare CSTL, FLGT, CDNA, BLLN side by side · Screen every company in Services-Medical Laboratories ↗